ArrowArtboardCreated with Sketch.Title ChevronTitle ChevronIcon FacebookIcon LinkedinIcon Mail ContactPath LayerIcon MailPositive ArrowIcon PrintIcon Twitter
Opinion

Indian-made COVID vaccines will save the world

China and US no match when it comes to manufacturing capacity and safety

| India
Vials of AstraZeneca's Covishield inside a lab at Serum Institute of India in Pune, pictured on Nov. 30: the COVID-19 vaccine is of particular value in developing nations.   © Reuters

Sreeram Chaulia is a professor and dean at the Jindal School of International Affairs in Sonipat, India. He is author of "Trumped: Emerging Powers in a Post-American World."

With vaccines from America's Pfizer and China's state-owned pharma group Sinopharm receiving their first overseas authorizations, the frantic race to produce and distribute the most-sought-after medicine in recent memory is on.

Sponsored Content

About Sponsored Content This content was commissioned by Nikkei's Global Business Bureau.

Discover the all new Nikkei Asia app

  • Take your reading anywhere with offline reading functions
  • Never miss a story with breaking news alerts
  • Customize your reading experience

Nikkei Asian Review, now known as Nikkei Asia, will be the voice of the Asian Century.

Celebrate our next chapter
Free access for everyone - Sep. 30

Find out more